Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
CareCredit : 0% financing for qualified patients
These elevated androgens can contribute to insulin resistance, which makes it incredibly difficult for the body to process sugar correctly and often leads to weight gain, especially around the midsection
Projected Timeline (Estimates, Not Confirmed) Phase 3 completion: Most TRIUMPH trials completing throughout 2026 NDA submission to FDA: Estimated late 2026 (depends on results across the full program) FDA review period: Typically 10-12 months for a standard review Approval decision: Estimated 2027, possibly earlier if Lilly seeks priority review Commercial availability (pharmacies): Several months after approval for manufacturing scale-up GlobalData, a pharmaceutical analytics firm, projects a 2027 approval with forecasted annual sales reaching $15.6 billion by 2031
For lupus nephritis patients, who face heightened risks of heart and kidney failure, GLP-1 receptor agonists could offer a much-needed lifeline
Do not double up
